WSJ News Exclusive | Merck in Late-Stage Talks to Acquire Prometheus Biosciences

Merck & Co. is in late-stage talks to acquire Prometheus Biosciences Inc., according to people familiar with the matter, a move that could give the big drugmaker promising immune disease treatments.

WSJ News Exclusive | Merck in Late-Stage Talks to Acquire Prometheus Biosciences

EDITOR'S PICK

Democrats target four California GOP members of Congress in effort to retake control of the House

On Juneteenth, one man’s unwavering quest for reparations

Why McCarthy and Biden both stand to gain from the debt deal — if they can get it passed

‘The Walking Dead’ family rallies around actor Erik Jensen after his Stage 4 cancer diagnosis

EP NEWSROOM

Unlocking Success: The Journey of Malek Bentchikou, a 23-Year-Old Algerian Trader

Former Dolton officer hired by Munster police despite ‘traumatic’ incidents at past job

Mia Sorety: Houston’s Rising Fitness Influencer Inspires Thousands to Embrace a Healthier Lifestyle

Grayslake data center could become largest county development; water and energy concerns remain

Keep moving in the right direction: Media Agency «Turtle» is calling!

Navigate Site

Welcome Back!

Retrieve your password

WSJ News Exclusive | Merck in Late-Stage Talks to Acquire Prometheus Biosciences

EDITOR'S PICK

EP NEWSROOM

Navigate Site

Follow Us

Welcome Back!

Retrieve your password